Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis - PubMed (original) (raw)
Expression of the cysteinyl leukotriene receptors cysLT(1) and cysLT(2) in aspirin-sensitive and aspirin-tolerant chronic rhinosinusitis
Chris Corrigan et al. J Allergy Clin Immunol. 2005 Feb.
Abstract
Background: Cysteinyl leukotrienes play a disease-regulating role in rhinosinusitis and asthma, particularly aspirin-sensitive disease. They act through 2 G-protein coupled receptors termed cysteinyl leukotriene type 1 receptor (cysLT 1 ) and cysteinyl leukotriene type 2 receptor (cysLT 2 ). We previously compared expression of cysLT 1 on mucosal leukocytes in patients with aspirin-sensitive and aspirin-tolerant rhinosinusitis.
Objective: To compare expression of cysLT 1 and cysLT 2 on leukocytes, mucus glands, and epithelium in 32 patients with chronic polypoid rhinosinusitis (21 aspirin-sensitive, 11 aspirin-tolerant) and 9 normal controls.
Methods: Total numbers of CD45 + leukocytes, percentages of these cells expressing cysLT 1 or cysLT 2 , and percentages of the total epithelial and glandular areas expressing cysLT 1 or cysLT 2 were measured in sections of nasal biopsies by using immunohistochemistry and image analysis.
Results: The percentages of mucosal CD45 + leukocytes expressing cysLT 1 were significantly ( P < .0001) elevated in the aspirin-sensitive but not the aspirin-tolerant patients compared with the controls. In contrast, the percentages of leukocytes expressing cysLT 2 did not differ significantly in the 3 groups. On epithelial and glandular cells, expression of cysLT 2 significantly exceeded that of cysLT 1 in both the patients with rhinosinusitis and the controls ( P < or = .004), although there was no significant difference in the expression of either receptor in the patients with rhinosinusitis (aspirin-sensitive or aspirin-tolerant) and the controls.
Conclusion: Although cysLT 1 expression predominates on inflammatory leukocytes in patients with aspirin-sensitive rhinosinusitis, the effects of cysteinyl leukotrienes on glands and epithelium may be mediated predominantly through cysLT 2. This has potentially important therapeutic implications.
Similar articles
- Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis.
Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Sousa AR, et al. N Engl J Med. 2002 Nov 7;347(19):1493-9. doi: 10.1056/NEJMoa013508. N Engl J Med. 2002. PMID: 12421891 Clinical Trial. - Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells.
Ying S, Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Ying S, et al. J Allergy Clin Immunol. 2006 Feb;117(2):312-8. doi: 10.1016/j.jaci.2005.10.037. J Allergy Clin Immunol. 2006. PMID: 16461132 - Gene expression profiling of nasal polyps associated with chronic sinusitis and aspirin-sensitive asthma.
Stankovic KM, Goldsztein H, Reh DD, Platt MP, Metson R. Stankovic KM, et al. Laryngoscope. 2008 May;118(5):881-9. doi: 10.1097/MLG.0b013e31816b4b6f. Laryngoscope. 2008. PMID: 18391768 - Phenomenology, pathogenesis, diagnosis and treatment of aspirin-sensitive rhinosinusitis.
Schapowal AG, Simon HU, Schmitz-Schumann M. Schapowal AG, et al. Acta Otorhinolaryngol Belg. 1995;49(3):235-50. Acta Otorhinolaryngol Belg. 1995. PMID: 7484142 Review. - Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK, Gupta S, Dastidar S, Ray A. Singh RK, et al. Pharmacology. 2010;85(6):336-49. doi: 10.1159/000312669. Epub 2010 Jun 2. Pharmacology. 2010. PMID: 20516735 Review.
Cited by
- Polymorphisms in Human IL4, IL10, and TNF Genes Are Associated with an Increased Risk of Developing NSAID-Exacerbated Respiratory Disease.
Reigada-Rivera ML, Lozano CS, Rodilla EM, García-Sánchez A, García-Solaesa V, Toledano FL, González ID, Isidoro-García M. Reigada-Rivera ML, et al. Genes (Basel). 2022 Mar 28;13(4):605. doi: 10.3390/genes13040605. Genes (Basel). 2022. PMID: 35456412 Free PMC article. - The Nose as a Route for Therapy: Part 1. Pharmacotherapy.
Cingi C, Bayar Muluk N, Mitsias DI, Papadopoulos NG, Klimek L, Laulajainen-Hongisto A, Hytönen M, Toppila-Salmi SK, Scadding GK. Cingi C, et al. Front Allergy. 2021 Feb 22;2:638136. doi: 10.3389/falgy.2021.638136. eCollection 2021. Front Allergy. 2021. PMID: 35387039 Free PMC article. Review. - Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s.
Bartemes KR, Kita H. Bartemes KR, et al. J Allergy Clin Immunol. 2021 May;147(5):1531-1547. doi: 10.1016/j.jaci.2021.03.015. J Allergy Clin Immunol. 2021. PMID: 33965091 Free PMC article. Review. - Leukotriene D4 paradoxically limits LTC4-driven platelet activation and lung immunopathology.
Liu T, Barrett NA, Nagai J, Lai J, Feng C, Boyce JA. Liu T, et al. J Allergy Clin Immunol. 2021 Jul;148(1):195-208.e5. doi: 10.1016/j.jaci.2020.10.041. Epub 2020 Dec 4. J Allergy Clin Immunol. 2021. PMID: 33285161 Free PMC article. - NSAID-Exacerbated Respiratory Disease (NERD): From Pathogenesis to Improved Care.
Woo SD, Luu QQ, Park HS. Woo SD, et al. Front Pharmacol. 2020 Jul 28;11:1147. doi: 10.3389/fphar.2020.01147. eCollection 2020. Front Pharmacol. 2020. PMID: 32848759 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous